CUTANEOUS MELANOMA
Clinical trials for CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone drug boosts immunotherapy in advanced melanoma trial
Disease control CompletedThis study tested whether adding denosumab (a bone-strengthening drug) to standard immunotherapy (pembrolizumab or nivolumab) could help control advanced melanoma that has spread. Twenty-five adults with stage III or IV melanoma that had not been treated with immunotherapy before…
Matched conditions: CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Immune cell therapy shows promise for Hard-to-Treat melanoma
Disease control CompletedThis early-phase study tested a new treatment called TBio-4101 for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells (TILs) that are grown in a lab and given back after chemotherapy and a drug called IL-2. Th…
Matched conditions: CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Doctor training boosts skin cancer detection
Knowledge-focused CompletedThis study looked at whether a special training program could help primary care doctors get better at spotting and managing early-stage melanoma, a serious skin cancer. Fifty-four doctors took part. The goal was to see if their knowledge and skills improved after the training, wh…
Matched conditions: CUTANEOUS MELANOMA
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Scientists test new way to spot Cancer-Fighting immune cells in lymph nodes
Knowledge-focused CompletedThis study tested a method to identify immune cells (T cells) that recognize unique mutations in tumors from patients with breast cancer or melanoma. Researchers looked at lymph nodes invaded by cancer to see if these cells were present. The goal was to see if the method works, n…
Matched conditions: CUTANEOUS MELANOMA
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC